Decker Retirement Planning’s Vertex Pharmaceuticals VRTX Stock Holding History

Decker Retirement Planning’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98K	Buy	+6	New	+$2.66K	﹤0.01%	326

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

Decker Retirement Planning's VRTX Position: Q2 2026 in Review

Decker Retirement Planning opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 6 shares worth $2.98K. The stake represents ﹤0.01% of the portfolio and ranks #326 among its holdings.

639 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Decker Retirement Planning held 6 shares of Vertex Pharmaceuticals worth $2.98K as of Q2 2026.
Vertex Pharmaceuticals was a new Decker Retirement Planning position in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of Decker Retirement Planning's portfolio in Q2 2026, its #326 holding.
639 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Decker Retirement Planning's 13F filing for Q2 2026, filed 16 Jul 2026.